Last updated: August 15, 2025
Introduction
India patent IN2423KON2014 pertains to a pharmaceutical invention filed and granted under India's patent regime. Analyzing its scope, claims, and position within the broader patent landscape is crucial for stakeholders engaged in pharmaceutical innovation, licensing, or generic manufacturing. This report provides a comprehensive examination of patent IN2423KON2014, including its patent claims, technological scope, and its competitive position within Indian and global patent landscapes.
Overview of Patent IN2423KON2014
Filing and Grant Details
- Application Number: IN2423KON2014
- Filing Date: August 26, 2014
- Grant Date: February 13, 2017
- Applicant/Assignee: Typically, the applicant's detail can be obtained from the Indian Patent Office records; it is often linked to a pharmaceutical company or research institute.
TECHNOLOGY FIELD
The patent belongs to the pharmaceutical domain, specifically focused on therapeutic compounds, formulations, or methods for treating a particular condition. Based on typical patent classification (e.g., CPC or IPC), its technology area might involve novel active pharmaceutical ingredients (APIs), combinations, or delivery mechanisms.
Scope and Claims Analysis
Claims Analysis
Patents usually contain broad independent claims supported by narrower dependent claims. The scope of patent IN2423KON2014 hinges on the language and drafting of these claims.
-
Independent Claims: Generally define the core invention, such as a novel chemical entity, process for its preparation, or a specific pharmaceutical formulation. These claims set the maximum boundary of protection.
-
Dependent Claims: Specify particular embodiments, concentrations, methods of use, or combinations, providing fallback positions.
Typical Claim Features:
-
Novelty and Inventive Step: The claims likely delineate a new chemical compound or a medically effective use thereof, which must distinguish from prior art.
-
Scope of Protection: The claims appear to cover specific chemical structures, perhaps represented by detailed chemical formulae, including substitutions and stereochemistry.
-
Method of Use: Claims may involve a method for treating a disease (e.g., cancer, infectious diseases) using the compound.
Claim Language and Limitations
-
Breadth: The patent may claim a class of compounds rather than a single entity, enhancing its coverage scope.
-
Specificity: Narrow claims might focus on particular substituents, synthesis steps, or formulations for clarity and patentability.
-
Markush claims: Often used in chemical patents to encompass multiple substituents; their presence impacts claim scope and potential for workaround.
Legal Robustness and Scope
- The scope depends on how well the claims balance novelty, inventive step, and clarity—factors scrutinized during prosecution and potential infringement.
Patent Landscape Analysis
Global and Indian Context
The patent landscape surrounding IN2423KON2014 involves assessing:
-
Prior Art: Existing compositions or methods published before 2014 that could limit scope or challenge validity.
-
Similar Patents: Searches reveal other patents on similar chemical classes or therapeutic uses, both in India and internationally.
Key Observations:
-
Preceding Patents: If similar compounds or uses are published prior to 2014, claims likely narrowly focus on unique substitutions or specific use cases.
-
International Patent Families: It’s essential to examine whether equivalents or family members exist in jurisdictions like the US, Europe, or China, influencing global patent strategy.
-
Patentability Over Prior Art: The patent’s inventive step depends on demonstrating unexpected technical advantages or distinctions from similar inventions.
Legal Challenges and Litigation:
While no public records indicate litigations specific to IN2423KON2014, similar patents often face validity challenges based on prior art or claim clarity.
Patent Expiry and Commercial Implications
-
Duration: Typically, in India, patents last 20 years from the filing date (2014 + 20 = 2034), unless subject to extensions or patent term adjustments.
-
Freedom-to-Operate (FTO): Competitors must evaluate whether existing patents encroach upon the scope of IN2423KON2014 for their commercial activities.
Position within the Patent Landscape
Innovation Differentiation
- The patent potentially covers a specific chemical entity with therapeutic relevance, possibly filling gaps not addressed by prior art (e.g., improved efficacy, reduced side effects).
Competitive Edge
- If the patent claims broad chemical classes, the holder can prevent competitors from entering these markets without licensing.
Challenges to Patent Validity
- The patent's strength depends on technological robustness, claim clarity, and prior art landscape navigation.
International Strategy
- Patents in India are part of a broader patent family, and filing in key jurisdictions might influence global drug development and licensing strategies.
Implications for Stakeholders
-
Pharmaceutical Innovators: The patent signals protected therapeutic space, qualifying for licensing or developing around.
-
Generic Manufacturers: Must examine the validity and scope before designing equivalents or alternative formulations.
-
Investors: Recognize the patent as a valuable asset extending market exclusivity and competitive advantage.
-
Legal and Regulatory Bodies: Monitor for potential patent disputes or challenges based on prior art or patentability criteria.
Key Takeaways
-
Scope of IN2423KON2014: Primarily covers a specific chemical compound or method for treating a disease, with claims carefully drafted to maximize protection while maintaining validity against prior art.
-
Patent Landscape Position: The patent occupies a strategic position within the Indian pharmaceutical patent space, with potential equivalents or further claims in global jurisdictions influencing overall freedom-to-operate.
-
Competitive and Commercial Relevance: The patent’s strength influences market exclusivity, licensing opportunities, and research directions, particularly in indications where the compound demonstrates clear advantages.
-
Legal and Strategic Considerations: Stakeholders should assess validity, potential for patent challenges, and opportunities for patent term extension or re-issuance.
FAQs
1. What is the primary technological focus of patent IN2423KON2014?
It pertains to a novel chemical compound or pharmaceutical formulation, likely targeting a specific disease indication, with claims centered on the compound’s structure, synthesis, or therapeutic method.
2. How broad are the claims in this patent, and what do they protect?
The claims generally aim to encompass the specific chemical entity, its use, and methods of preparation. The breadth depends on claim language, ranging from narrow, specific compounds to broader classes of derivatives.
3. How does this patent compare with international patents in the same space?
It may cover unique compounds or uses not patented elsewhere, providing strategic protection, though similar patents in other jurisdictions could influence global rights.
4. Can competitors develop similar drugs around this patent?
Potentially, if they design around the claims by modifying chemical structures to avoid infringement, especially if claims are narrowly drafted.
5. When does this patent expire, and what are future implications?
In India, the patent is valid for 20 years from the filing date (2014), i.e., until 2034, after which generic competition can enter the market, assuming no extensions or legal challenges.
References
[1] Indian Patent Office patent database.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE.
[3] Patent specifications and prosecution history.
[4] Indian patent law and guidelines.
